The conclusions from previous molecular docking studies suggest PTP1B, α-glucosidase, DPP-IV, and PPAR-γ as plausible targets that explain the hypoglycemia activity of MB extract [42,43,44]. This evidence concerns the gene PPARG and Hypoglycemia.